Meet the Research Team -

Home
About
Participate
Clinicians
The Team
Locations
Articles
Contact Us!

Click on each team member to learn more about them!

Boston PRECIDENTD Team

Dr. Brendan Everett, MD, MPH

Co-Lead of the PRECIDENTD Clinical Coordinating Center

Dr. Brendan Everett, MD, MPH

Co-Lead of the PRECIDENTD Clinical Coordinating Center

Brendan M. Everett is a cardiologist (heart doctor) at Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS). Dr. Everett’s work is focused on preventing heart attack, heart failure, stroke, amputation, and death from heart disease in people with type 2 diabetes. He believes the PRECIDENTD study will provide people with diabetes and their doctors with important information to help them decide how best to treat their disease and to prevent heart attack, heart failure, stroke, and other diseases.

Dr. Robert J. Glynn, PhD, ScD

Lead of the PRECIDENTD Data Coordinating Center

Dr. Robert J. Glynn, PhD, ScD

Lead of the PRECIDENTD Data Coordinating Center

Robert J. Glynn is a biostatistician at Brigham and Women’s Hospital, a Professor at Harvard Medical School, and a Professor in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. He has been responsible for the design, safety monitoring, and analysis of many multicenter randomized trials studying the best ways to lower the risk of heart disease, the leading cause of death in people with diabetes. He believes that through collaboration with the participants in the PRECIDENTD study and their caregivers, we can collect high-quality data to elucidate their treatment decisions.

Dr. Deborah J. Wexler, MD, MSc.

Co-Lead of the PRECIDENTD Clinical Coordinating Center

Dr. Deborah J. Wexler, MD, MSc.

Co-Lead of the PRECIDENTD Clinical Coordinating Center

Deborah J. Wexler is a diabetologist (diabetes specialist) and Clinical Director of the Massachusetts General Hospital Diabetes Center and Associate Professor at Harvard Medical School. Dr. Wexler’s work has been focused on finding the most effective ways to treat type 2 diabetes. She is excited to be partnering with people with diabetes and their caregivers to answer the next most pressing question in how best to treat people with diabetes with heart disease or high heart disease risk.

Stakeholder Engagement Team

Dr. Lyndsay Nelson, PhD

Vanderbilt Stakeholder Engagement Team

Dr. Lyndsay Nelson, PhD

Vanderbilt Stakeholder Engagement Team

Lyndsay Nelson is a social and behavioral scientist at Vanderbilt University Medical Center in Nashville, TN. Dr. Nelson’s research is focused on helping patients better manage their type 2 diabetes using mobile health. She is excited to work with stakeholders to ensure the PRECIDENTD study design, materials, and protocols are acceptable, appropriate, and feasible.

Dr. Lindsay Mayberry, PhD, MS

Vanderbilt Stakeholder Engagement Team

Dr. Lindsay Mayberry, PhD, MS

Vanderbilt Stakeholder Engagement Team

Lindsay Mayberry is a family and community psychologist at Vanderbilt University Medical Center in Nashville, TN. Dr. Mayberry’s research uses technology and family/friend involvement to help improve the lives of patients with diabetes. She has expertise in community engagement methods and looks forward to engaging patient and professional stakeholders for the PRECIDENTD study.

Columbia University PRECIDENTD Team

Dr. Jacqueline Lonier, MD

Columbia University Principal Investigator

Dr. Jacqueline Lonier, MD

Columbia University Principal Investigator

Jacqueline Lonier is an endocrinologist at the Naomi Berrie Diabetes Center and an Assistant Professor of Medicine at Columbia University Irving Medical Center. Dr. Lonier currently serves as Associate Director of the Berrie Center clinical diabetes program. Her research and clinical work focuses on diabetes management. She is thrilled to be working with the PRECIDENTD study team and participants to help answer important questions about the prevention of cardiovascular disease in people with diabetes.

Duke University PRECIDENTD Team

Dr. W. Schuyler Jones, MD

Duke University Principal Investigator

Dr. W. Schuyler Jones, MD

Duke University Principal Investigator

W. Schuyler Jones is an interventional cardiologist and an Associate Professor of Medicine at Duke University School of Medicine. His clinical interests include peripheral artery disease, coronary artery disease, and percutaneous coronary intervention. He currently serves as the Director of the Duke University Cardiac Catheterization Laboratory. Dr. Jones is an investigator at the Duke Clinical Research Institute where he is the medical director of the Duke Heart Center Clinical Research Unit. He has been part of the leadership team for several clinical trials across a broad spectrum of cardiovascular care. He is a co-principal investigator of the PCORI-funded demonstration project called Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study which is enrolling 15,000 patients with established cardiovascular disease at 40 clinical sites within PCORnet. He is also the chair of the Recruitment and Retention Core for the PREVENTABLE study which will enroll 20,000 patients over 75 years of age without established cardiovascular disease at PCORnet and Veterans Affairs centers.

Dr. Ranee Chatterjee Montgomery, MD

Duke University Co-Investigator

Dr. Ranee Chatterjee Montgomery, MD

Duke University Co-Investigator

Ranee Chatterjee-Montgomery is a general internist, clinical investigator and Associate Professor of Medicine at Duke University. She is the associate director of Duke's Primary Care Research Consortium (PCRC), which is a practice-based research network of primary care clinics of Duke. She has research interests in chronic disease prevention and treatment in primary care. She has led several multi-site trials through PCRC and is happy to be a part of the PRECIDENTD study.

Essentia Health Team

Dr. Catherine Benziner, MD, MPH, FACC, FAHA

Essential Health Principal Investigator

Dr. Catherine Benziner, MD, MPH, FACC, FAHA

Essential Health Principal Investigator

Catherine Benziger is a cardiologist at Essentia Health specializing in echocardiography, heart disease prevention and clinical research. She is an adjunct associate professor at the University of Minnesota Medical School, Duluth Campus. Since becoming a medical director of heart and vascular research at Essentia Health in 2017, she has led a large research team as site PI for multiple clinical trials. Dr. Benziger'sm work focuses on improving cardiovascular health in rural areas, including prevention of diabetes, hypertension, and cholesterol through research and education. She believes the PRECIDENTD study is important because diabetes is very common and it will help us understand which treatment is best at preventing heart attacks, strokes, and other diseases.

Johns Hopkins University PRECIDENTD Team

Dr. Rita Kalyani, MD, MHS

Johns Hopkins University Principal Investigator

Dr. Rita Kalyani, MD, MHS

Johns Hopkins University Principal Investigator

Rita Kalyani is an Associate Professor of Medicine at Johns Hopkins School of Medicine, Core Faculty at the Johns Hopkins Center on Aging and Health, and Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health.

Dr. Jodi Segal, MD, MPH

Johns Hopkins University Co-Investigator

Dr. Jodi Segal, MD, MPH

Johns Hopkins University Co-Investigator

Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology.

University of Missouri PRECIDENTD Team

Dr. Camila Manrique Acevedo, MD

University of Missouri Principal Investigator

Dr. Camila Manrique Acevedo, MD

University of Missouri Principal Investigator

Camila Manrique Acevedo is an Associate Professor with tenure in the Division of Endocrinology at the University of Missouri. She is the Faculty Director for Research Operations in the Department of Medicine and the Chief of Endocrinology at the Harry S Truman VA Hospital.

Medical University of South Carolina PRECIDENTD Team

Dr. Harsha Karanchi, MD

MUSC Principal Investigator

Dr. Harsha Karanchi, MD

MUSC Principal Investigator

Harsha Karanchi is an endocrinologist with expertise in diabetes and an Associate Professor of Medicine at the Medical University of South Carolina. Dr. Karanchi's work is focused on preventing complications of diabetes and improving healthspan, the part of a person’s life spent in good health. He believes PRECIDENTD brings unique opportunities for South Carolinians with type 2 diabetes to use approved diabetes medications with proven heart and kidney benefits, while helping answer an important question on the best medication to prevent and reduce the risk of heart and kidney disease.

Dr. Marc Cornier, MD

MUSC Co-Investigator

Dr. Marc Cornier, MD

MUSC Co-Investigator

Marc Cornier is Professor of Medicine, James A. Keating Endowed Chair in Diabetes, and Director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina. Dr Cornier’s clinical work and research are focused on diabetes and obesity. He is very interested in heart disease prevention and how to best approach this in patients with diabetes.

Vanderbilt University PRECIDENTD Team

Dr. Leslee Matheny, MD

Vanderbilt Principal Investigator

Dr. Leslee Matheny, MD

Vanderbilt Principal Investigator

Leslee Matheny is an Assistant Professor in the division of Diabetes, Endocrinology and Metabolism at Vanderbilt University Medical Center. As an endocrinologist, Dr. MAtheny sees many patients with type 2 diabetes in her practice, and is invested in finding which medications are best at mitigating potential long-term effects of the disease.

Dr. Russell L. Rothman, MD, MPP

Vanderbilt Co-Investigator

Dr. Russell L. Rothman, MD, MPP

Vanderbilt Co-Investigator

Russell Rothman is Professor of Internal Medicine, Pediatrics and Health Policy, Ingram Professor of Integrative and Population Health, and the Senior Vice President for Population and Public Health at Vanderbilt University Medical Center. He also serves as the Director of the Institute for Medicine and Public Health and Associate Dean for Population Health Sciences. His research focuses on improving care for adult and pediatric patients with diabetes, obesity and other chronic diseases. He is currently the Principal Investigator of the PCORI funded STAR (Stakeholders, Technology and Research) Clinical Research Network, which engages Vanderbilt, Meharry, Duke, UNC, Wake Forest, Health Sciences of South Carolina, and Mayo in real world evidence and pragmatic research and include electronic health data on over 14 million patients. Dr. Rothman serves as Chair of the PCORI PCORnet Executive Steering Committee, a national network of over 60 health systems that supports comparative effectiveness research and pragmatic clinical trials.

Medical College of Wisconsin PRECIDENTD Team

Dr. Jake Decker, MD

MCW Principal Investigator

Dr. Jake Decker, MD

MCW Principal Investigator

Jake Decker is a general internist and primary care physician at Froedtert Hospital and Assistant Professor of Medicine at the Medical College of Wisconsin in Milwaukee, WI. Dr. Decker’s professional interests include preventative medicine and management of chronic conditions. He is looking forward to helping identify the best strategies to prevent heart disease in people with type 2 diabetes as part of the PRECIDENTD trial.

Dr. Jeffrey Whittle, MD, MPH

MCW Principal Co-Investigator

Dr. Jeffrey Whittle, MD, MPH

MCW Principal Co-Investigator

Jeffrey Whittle is a Staff Physician at the Clement J. Zablocki VA Medical Center and Professor of Medicine in the Division of General Internal Medicine. He attended the Medical College of Wisconsin then received his internal medicine residency training at the University of Alabama – Birmingham.

Home
About Us
For Clinicians
Meet the Research Team
Study Locations
Articles
Contact

Medical Care WordPress Theme